Once BCG unresponsive, always BCG unresponsive: An open letter to the FDA to enhance recruitment into clinical trials in bladder cancer

Ashish M. Kamat, Seth Lerner, Peter Black, Joaquim Bellmunt, Colin Dinney, Noah M. Hahn, Michael O'Donnell, Diane Z. Quale

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Once BCG unresponsive, always BCG unresponsive: An open letter to the FDA to enhance recruitment into clinical trials in bladder cancer'. Together they form a unique fingerprint.